FDA fast-tracks Leap’s gastric cancer immunotherapyLeap Therapeutics will get a swift FDA review for its lead drug DKN-01 for a form of gastric Share XFDA fast-tracks Leap’s gastric cancer immunotherapyhttps://pharmaphorum.com/news/fda-fast-tracks-leaps-gastric-cancer-immunotherapy/
Pieris begins gastric cancer combination trial with Lilly’s CyramzaUS biotech Pieris Pharmaceuticals has begun a collaboration and supply agreement with Eli Lilly, trialling its cancer drug Share XPieris begins gastric cancer combination trial with Lilly’s Cyramzahttps://pharmaphorum.com/news/pieris-begins-gastric-cancer-combination-trial-with-lillys-cyramza/
AstraZeneca to unveil key data for cancer drugs at ASCOAstraZeneca plans to unveil data at this year’s American Society of Clinical Oncology (ASCO) conference that could expand Share XAstraZeneca to unveil key data for cancer drugs at ASCOhttps://pharmaphorum.com/news/astrazeneca-to-unveil-key-data-for-cancer-drugs-at-asco/
Merck’s Keytruda fails in gastric cancer trialTrial missed overall survival endpoint Share XMerck’s Keytruda fails in gastric cancer trialhttps://pharmaphorum.com/news/mercks-keytruda-fails-gastric-cancer-trial/
